INST VIROLOGY has a total of 42 patent applications. Its first patent ever was published in 1995. It filed its patents most often in EPO (European Patent Office), Japan and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are KITAMURA TOSHIO, A & G PHARMACEUTICALS INC and BEIJING SUNBIO BIOTECH CO LTD.
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Measuring microorganism processes | |
#7 | Heterocyclic compounds | |
#8 | Measuring length, angles and areas | |
#9 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Pastorek Jaromir | 40 |
#2 | Pastorekova Silvia | 38 |
#3 | Zavada Jan | 28 |
#4 | Zavadova Zuzanna | 15 |
#5 | Zatovicova Miriam | 14 |
#6 | Ortova Gut Marta | 14 |
#7 | Supuran Claudiu | 10 |
#8 | Scozzafava Andrea | 9 |
#9 | Jaromir Pastorek | 2 |
#10 | Ebert Matthias | 2 |
Publication | Filing date | Title |
---|---|---|
AU2012211499A1 | CA IX-specific inhibitors | |
AU2008200868A1 | Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erb-B2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes | |
EP2076611A2 | Mn/ca9 splice variants | |
AU2007219349A1 | CA IX-specific inhibitors | |
EP1569633A2 | Ca ix-specific inhibitors | |
AU2003223186A1 | SOLUBLE FORM OF CARBONIC ANHYDRASE IX (s-CA IX), ASSAYS TO DETECT s-CA IX AND CA IX's COEXPRESSION WITH HER-2/neu/c-erbB-2 | |
EP2508596A2 | MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use | |
HUE026277T2 | Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use | |
CA2192678A1 | Mn gene and protein | |
EP1595947A1 | MN gene and protein |